1 min read •
GENOPOLE Evry : le virage stratégique se confirme
Over the last 5 years, the world biopharmaceutical market has reached an 18 % growth rate. In 2011, it could rise up to USD 114 billion according to a 2005 study conducted by Arthur D Little.
Over the last 5 years, the world biopharmaceutical market has reached an 18 % growth rate. In 2011, it could rise up to USD 114 billion according to a 2005 study conducted by Arthur D Little.
RELATED INFORMATION
The BIG patent expiry question: Why sink when you can sail?
As a biopharmaceutical product approaches the end of its patent life, executives believe that the product’s demise is inevitable and will happen at great speed. They begin to worry about the rapid…
Arthur D. Little sees mobile payments surging ahead with distinct opportunities in developed and emerging markets
In the last five years, markets with mobile payment offers have matured with a variety of players entering the industry value chain and new services being launched. Initially, there was a race to…
A sky full of eyes – Commercial opportunity in Earth observation
600+ Earth observation satellites are constantly keeping an eye on us from space – is there a commercial opportunity in Earth watching, and how can companies play in this space? The Earth observation…